GlassScriptPhysician profile
Roger W Jump
NPI 1639467517
$9,419.76
in general payments reported to CMS, 2019-2025
51 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,717 · 2020: $646 · 2021: $2,388 · 2022: $752 · 2023: $1,433 · 2024: $1,166 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,811 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,811.31 |
| Education | $104.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,239.61 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Teleflex LLC | $1,182.38 | 2021-2025 | Urolift, Barrigel |
| Abbvie INC. | $774.45 | 2019-2025 | |
| Astellas Pharma US INC | $538.18 | 2019-2025 | Xtandi |
| Coloplast Corp | $477.98 | 2019-2025 | Titan, Altis, Speedicath |
| Merz North America, INC. | $421.19 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $372.76 | 2020-2025 | Lynparza |
| Pfizer INC. | $338.15 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $281.99 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $272.69 | 2019-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $272.61 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $256.81 | 2023-2025 | Orgovyx, Gemtesa |
| Verity Pharmaceuticals INC. | $220.60 | 2022-2025 | Trelstar |
| Blue Earth Diagnostics | $217.39 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $178.39 | 2019-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $173.93 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $163.21 | 2019-2022 | |
| Clarus Therapeutics INC. | $157.48 | 2021 | |
| Axonics, INC. | $137.77 | 2020-2024 | Bulkamid, Axonics |
| C. R. Bard, INC. & Subsidiaries | $134.19 | 2020-2021 | |
| Allergan, INC. | $121.80 | 2019-2021 | |
| Urogen Pharma, INC. | $121.64 | 2022-2025 | Jelmyto |
| Procept Biorobotics Corporation | $114.14 | 2022-2024 | Aquabeam System |
| Medtronic, INC. | $97.69 | 2022-2023 | Interstim |
| Accord Healthcare, INC. | $94.85 | 2023-2024 | |
| Tolmar, INC. | $94.53 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $84.57 | 2022-2025 | Prolaris |
| Cook Medical LLC | $72.86 | 2019-2023 | Resonance |
| Immunitybio, INC. | $67.75 | 2024-2025 | |
| Olympus Corporation of The Americas | $65.00 | 2023 | Itind System |
| Sun Pharmaceutical Industries INC. | $64.40 | 2022-2024 | |
| Olympus America INC. | $61.63 | 2019-2025 | Itind System |
| 180 Medical, INC. | $59.58 | 2021-2023 | |
| Myovant Sciences INC. | $57.74 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $48.08 | 2021-2023 | Xiaflex |
| Ferring Pharmaceuticals INC. | $47.00 | 2024-2025 | Adstiladrin |
| Genzyme Corporation | $46.04 | 2021-2022 | |
| Agiliti Surgical, INC. | $43.81 | 2023 | Sonablate, Greenlight Xps, Cryocare Cs |
| Laborie Medical Technologies Corp. | $36.81 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Vertex Pharmaceuticals Incorporated | $26.56 | 2025 | |
| Caldera Medical, INC | $22.91 | 2021 | |
| Angiodynamics, INC. | $21.27 | 2025 | Nanoknife |
| Ethicon US, LLC | $20.52 | 2019 | |
| Progenics Pharmaceuticals, INC. | $19.87 | 2024 | |
| Smith+Nephew, INC. | $18.01 | 2023 | Grafix |
| Civco Medical Instruments | $18.00 | 2024 | |
| Antares Pharma, INC. | $15.55 | 2021 | |
| Photocure INC | $14.14 | 2024 | Cysview |
| Amgen INC. | $11.69 | 2019 | |
| Acerus Pharmaceuticals Corporation | $11.44 | 2021 | |
| Travere Therapeutics, INC. | $8.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Jump listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.